Meelan Bul

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. doi request reprint Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 63:597-603. 2013
  2. doi request reprint Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 110:1672-7. 2012
  3. doi request reprint Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 62:195-200. 2012
  4. doi request reprint Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 61:370-7. 2012
  5. doi request reprint Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam
    Meelan Bul
    Department of Urology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
    Eur Urol 59:498-505. 2011
  6. ncbi request reprint Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality
    Pim J van Leeuwen
    Erasmus University Medical Center, Rotterdam, The Netherlands
    Can J Urol 18:6018-24. 2011
  7. doi request reprint Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur Urol 60:330-6. 2011
  8. doi request reprint Towards an optimal interval for prostate cancer screening
    Pim J van Leeuwen
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 61:171-6. 2012
  9. doi request reprint Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Room NH 227, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Med Screen 19:133-40. 2012
  10. doi request reprint Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators
    Monique J Roobol
    Erasmus University Medical Centre, Department of Urology, Rotterdam, The Netherlands
    Eur Urol 61:577-83. 2012

Collaborators

Detail Information

Publications18

  1. doi request reprint Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 63:597-603. 2013
    ..Overdiagnosis and subsequent overtreatment are important side effects of screening for, and early detection of, prostate cancer (PCa). Active surveillance (AS) is of growing interest as an alternative to radical treatment of low-risk PCa...
  2. doi request reprint Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 110:1672-7. 2012
    ..Favourable disease-specific outcomes confirm the feasibility of active surveillance for low risk PCa and also support a role for active surveillance in selected patients with intermediate risk PCa...
  3. doi request reprint Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 62:195-200. 2012
    ..Little is known about the outcome of radical prostatectomy (RP) in men initially followed on active surveillance (AS) for low-risk prostate cancer (PCa)...
  4. doi request reprint Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
    Meelan Bul
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 61:370-7. 2012
    ..Active surveillance (AS) protocols for low-risk prostate cancer (PCa) generally include repeat prostate biopsies at predefined follow-up intervals...
  5. doi request reprint Prostate cancer incidence and disease-specific survival of men with initial prostate-specific antigen less than 3.0 ng/ml who are participating in ERSPC Rotterdam
    Meelan Bul
    Department of Urology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
    Eur Urol 59:498-505. 2011
    ..The European Randomised Study of Screening for Prostate Cancer (ERSPC) applies a prostate-specific antigen (PSA) cut-off value ≥3.0 ng/ml as an indication for lateralised sextant biopsy...
  6. ncbi request reprint Critical assessment of prebiopsy parameters for predicting prostate cancer metastasis and mortality
    Pim J van Leeuwen
    Erasmus University Medical Center, Rotterdam, The Netherlands
    Can J Urol 18:6018-24. 2011
    ..Value of characteristics assessed prior to diagnosis predicting aggressive prostate cancer, metastases and mortality in men participating in a screening study were identified...
  7. doi request reprint Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Eur Urol 60:330-6. 2011
    ..In a screening program, interval cancers are cancers diagnosed between two screening visits...
  8. doi request reprint Towards an optimal interval for prostate cancer screening
    Pim J van Leeuwen
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Eur Urol 61:171-6. 2012
    ..The rate of decrease in advanced cancers is an estimate for determining prostate cancer (PCa) screening program effectiveness...
  9. doi request reprint Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Room NH 227, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Med Screen 19:133-40. 2012
    ..To assess the impact of different study designs on outcome data within the European Randomized Study of Screening for Prostate Cancer (ERSPC)...
  10. doi request reprint Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators
    Monique J Roobol
    Erasmus University Medical Centre, Department of Urology, Rotterdam, The Netherlands
    Eur Urol 61:577-83. 2012
    ..The European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculators (RCs) are validated tools for prostate cancer (PCa) risk assessment and include prostate volume (PV) data from transrectal ultrasound (TRUS)...
  11. ncbi request reprint Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method
    Xiaoye Zhu
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    Can J Urol 20:6756-60. 2013
    ..To assess the extent of overestimation of the cumulative probability of death by the Kaplan-Meier method with the competing-risks regression analysis as reference approach...
  12. doi request reprint The Prostate cancer Research International: Active Surveillance study
    Chris H Bangma
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Curr Opin Urol 22:216-21. 2012
    ..To inform readers on the ongoing activities of the Prostate cancer Research International: Active Surveillance (PRIAS) study in the light of current findings and research problems on active surveillance worldwide...
  13. doi request reprint Positive predictive value of prostate biopsy indicated by prostate-specific-antigen-based prostate cancer screening: trends over time in a European randomized trial*
    Leonard P Bokhorst
    Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands
    BJU Int 110:1654-60. 2012
    ..In men who have previously had a benign biopsy, the PPV drops considerably, but 20% of the cancers detected still show aggressive characteristics...
  14. doi request reprint Increased non-prostate cancer death risk in clinically diagnosed prostate cancer
    Pim J van Leeuwen
    Department of Urology Public Health, Erasmus Medical Centre, Rotterdam Cancer Registry Rotterdam, Rotterdam, The Netherlands
    BJU Int 110:188-94. 2012
    ..Men with clinically diagnosed PC have an increased risk of death unrelated to PC itself, i.e., the excess mortality is based on an increased risk of dying from other neoplasm and diseases of the circulatory or respiratory system...
  15. doi request reprint Active surveillance for low-risk prostate cancer
    Chris H Bangma
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Crit Rev Oncol Hematol 85:295-302. 2013
    ....
  16. doi request reprint Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam)
    Xiaoye Zhu
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Int J Cancer 129:2847-54. 2011
    ..Subsequently, we can achieve improvements of the current screening algorithm, which hopefully will further decrease PCa-specific mortality without increasing overdiagnosis and overtreatment...
  17. ncbi request reprint Updating the prostate cancer risk indicator for contemporary biopsy schemes
    Meelan Bul
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Can J Urol 18:5625-9. 2011
    ..Our objective is to extract correction factors for adjustment of the model, addressing contemporary extended biopsy schemes...
  18. doi request reprint Screening for prostate cancer---the controversy continues, but can it be resolved?
    Meelan Bul
    Department of Urology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    Acta Oncol 50:4-11. 2011
    ..Contradictory results caused considerable discussion and misunderstanding in secondary literature...